Skip to main content

VivoSim Labs, Inc. (VIVS) Stock

VivoSim Labs, Inc. Stock Details, Movements and Public Alerts

Stock Details

VivoSim Labs, Inc. (VIVS), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the NCM.Currently, the stock is trading at $0.28. Over the past 52 weeks, it has ranged between $0.26 and $5.30. This places the current price at 5.3% of its 52-week high and 7.7% above its 52-week low. Recent trading volume was recorded at 387,744. The 14-day Relative Strength Index (RSI) stands at 31.17, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $0.50 by 44.00%. Similarly, it is below its 200-day moving average of $1.44 by 80.56%. The MACD histogram is 0.02, indicating bullish momentum (MACD Line: -0.06, Signal Line: -0.08). There are currently 3 active alerts set for VIVS by users.

52-Week Range

$5.30 - $0.26

-94.72% from high · +7.69% from low

Avg Daily Volume

1,311,156

20-day average

100-day avg: 3,577,433

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

0.16

EV/EBITDA

-0.25

EPS (TTM)

-$4.46

Price to Sales

33.26

Beta

1.45

Similar volatility to market

Q:How is VIVS valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is VIVS's risk profile compared to the market?
With a beta of 1.45, VivoSim Labs, Inc. is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 0.16 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-15327.78%

EBITDA

$-11,137,000

Return on Equity

-343.10%

Return on Assets

-89.50%

Revenue Growth (YoY)

-51.40%

Q:How profitable and efficient is VIVS's business model?
0 The operating margin of -15327.78% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -343.10% and ROA at -89.50%, the company achieves moderate returns on invested capital.
Q:What are VIVS's recent growth trends?
VivoSim Labs, Inc.'s revenue declined by 51.40% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. These growth metrics should be evaluated against Biotechnology industry averages for proper context.

Company Size & Market

Market Cap

$3.7M

Revenue (TTM)

$112,000

Revenue/Share (TTM)

$0.03

Shares Outstanding

13.39M

Book Value/Share

$1.70

Asset Type

EQUITY

Q:What is VIVS's market capitalization and position?
VivoSim Labs, Inc. has a market capitalization of $3.7M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 13.39M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does VIVS's price compare to its book value?
VivoSim Labs, Inc.'s book value per share is $1.70, while the current stock price is $0.28, resulting in a price-to-book (P/B) ratio of 0.16. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As EQUITY, this represents a specific type of security.

Fundamentals last updated: Sep 8, 2026, 02:25 AM

Technical Indicators

RSI (14-day)

31.17

Neutral

50-Day Moving Average

$0.50

-44.00% below MA-50

200-Day Moving Average

$1.44

-80.56% below MA-200

MACD Line

-0.06

MACD Signal

-0.08

MACD Histogram

0.02

Bullish

Q:What does VIVS's RSI value tell investors?
The RSI (Relative Strength Index) for VIVS is currently 31.17, indicating the stock is showing bearish momentum (30-40 range). Selling pressure is evident but not extreme. This often occurs during pullbacks in uptrends or early stages of downtrends. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret VIVS's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.06 above the signal line at -0.08, with histogram at 0.02. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.50) is below the 200-day MA ($1.44), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Sep 8, 2026, 12:31 AM

Active Alerts

Alert Condition
Price falls below
Threshold
$0.25
Created
Aug 26, 2026, 03:57 PM
Alert Condition
RSI Threshold Cross
Threshold
30
Created
Aug 19, 2026, 03:59 PM
Alert Condition
Price rises above
Threshold
$0.77
Created
Aug 17, 2026, 04:00 PM

Stay Ahead of the Market with VivoSim Labs, Inc. Alerts

Set up price alerts for VivoSim Labs, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.